Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Julie Rich Ingelfinger, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01DK058950 (INGELFINGER, JULIE R.) Sep 30, 2000 - Jul 31, 2005
    NIH
    PROXIMAL TUBULE ANGIOTENSINS--HEMOLYTIC UREMIC SYNDROME
    Role: Principal Investigator
  2. K08DK002048 (INGELFINGER, JULIE R.) Jun 1, 1993 - Jan 31, 2002
    NIH
    INTRACELLULAR PROCESSING OF RAT KIDNEY RENIN
    Role: Principal Investigator
  3. R01HL048455 (INGELFINGER, JULIE R.) May 1, 1992 - Mar 31, 2002
    NIH
    ROLES OF THE PROXIMAL TUBULE RENIN ANGIOTENSIN SYSTEM
    Role: Principal Investigator
  4. R01HL040210 (INGELFINGER, JULIE R.) Mar 1, 1988 - Feb 28, 1992
    NIH
    INTRARENAL ANGIOTENSINOGEN: LOCALIZATION ®ULATION
    Role: Principal Investigator
  5. F33HL006913 (INGELFINGER, JULIE R.) Feb 6, 1985
    NIH
    ONTOGENY OF RENIN IN PERINATAL LIFE
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Williams WW, Ingelfinger JR. Inhibiting APOL1 to Treat Kidney Disease. N Engl J Med. 2023 Mar 16; 388(11):1045-1049. PMID: 36920762.
    Citations:    Fields:    
  2. Leopold JA, Ingelfinger JR. Aldosterone and Treatment-Resistant Hypertension. N Engl J Med. 2023 Feb 02; 388(5):464-467. PMID: 36724334.
    Citations:    Fields:    Translation:Humans
  3. Aronne LJ, Bramblette S, Ingelfinger JR, Jastreboff AM, Machineni S, Massie N, Rosen CJ. When Weight Impacts Health. N Engl J Med. 2023 01 12; 388(2):e2. PMID: 36630621.
    Citations:    Fields:    
  4. Ingelfinger JR. Youth with single kidneys-what is the evidence of risk? Kidney Int. 2023 01; 103(1):28-30. PMID: 36603980.
    Citations:    Fields:    Translation:Humans
  5. Aronne LJ, Bramblette S, Huett-Garcia A, Ingelfinger JR, Jastreboff AM, Machineni S, Massie N, Rosen CJ. Weight and Health - Pathophysiology and Therapies. N Engl J Med. 2022 12 15; 387(24):e62. PMID: 36516089.
    Citations:    Fields:    
  6. Ingelfinger JR. Thiazide-like versus Thiazide Diuretics - Finally, an Answer? N Engl J Med. 2022 12 29; 387(26):2462-2463. PMID: 36516077.
    Citations:    Fields:    Translation:Humans
  7. Ingelfinger JR. Discontinuation of RAS Inhibitors in Advanced CKD - Has Equipoise Occurred? N Engl J Med. 2022 12 01; 387(22):2083-2084. PMID: 36449425.
    Citations:    Fields:    Translation:Humans
  8. Zhao XP, Chang SY, Pang Y, Liao MC, Peng J, Ingelfinger JR, Chan JSD, Zhang SL. Hedgehog interacting protein activates sodium-glucose cotransporter 2 expression and promotes renal tubular epithelial cell senescence in a mouse model of type 1 diabetes. Diabetologia. 2023 01; 66(1):223-240. PMID: 36260124.
    Citations:    Fields:    Translation:HumansAnimalsCells
  9. Ingelfinger JR. A new era for steroid-resistant nephrotic syndrome in childhood. Kidney Int. 2022 09; 102(3):471-473. PMID: 35988934.
    Citations:    Fields:    Translation:Humans
  10. Rhee CM, Edwards D, Ahdoot RS, Burton JO, Conway PT, Fishbane S, Gallego D, Gallieni M, Gedney N, Hayashida G, Ingelfinger J, Kataoka-Yahiro M, Knight R, Kopple JD, Kumarsawami L, Lockwood MB, Murea M, Page V, Sanchez JE, Szepietowski JC, Lui SF, Kalantar-Zadeh K. Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference Proceedings. Kidney Int Rep. 2022 Sep; 7(9):1951-1963. PMID: 36090498; PMCID: PMC9459054.
    Citations:    
  11. Haley JE, Woodly SA, Daniels SR, Falkner B, Ferguson MA, Flynn JT, Hanevold CD, Hooper SR, Ingelfinger JR, Khoury PR, Lande MB, Martin LJ, Meyers KE, Mitsnefes M, Becker RC, Rosner BA, Samuels J, Tran AH, Urbina EM. Association of Blood Pressure-Related Increase in Vascular Stiffness on Other Measures of Target Organ Damage in Youth. Hypertension. 2022 09; 79(9):2042-2050. PMID: 35762327; PMCID: PMC9378473.
    Citations: 2     Fields:    Translation:Humans
  12. Sacks CA, Ingelfinger JR, Taichman DB, Morrissey S, Malina D, Phimister EG, Stern KL, Duff EMC, Hogan JW, Rubin EJ. Nineteen Days in America. N Engl J Med. 2022 06 30; 386(26):2445-2449. PMID: 35675201.
    Citations: 2     Fields:    
  13. Rosen CJ, Ingelfinger JR. Shifting Tides Offer New Hope For Obesity. N Engl J Med. 2022 07 21; 387(3):271-273. PMID: 35657317.
    Citations:    Fields:    Translation:Humans
  14. Price JJ, Urbina EM, Carlin K, Becker R, Daniels SR, Falkner BE, Ferguson M, Hanevold C, Hooper SR, Ingelfinger JR, Lande MB, Martin LJ, Meyers K, Mitsnefes M, Rosner B, Samuels J, Flynn JT. Cardiovascular Risk Factors and Target Organ Damage in Adolescents: The SHIP AHOY Study. Pediatrics. 2022 06 01; 149(6). PMID: 35502610; PMCID: PMC9648121.
    Citations: 2     Fields:    Translation:Humans
  15. Liao MC, Miyata KN, Chang SY, Zhao XP, Lo CS, El-Mortada MA, Peng J, Chenier I, Yamashita M, Ingelfinger JR, Chan JSD, Zhang SL. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice. Clin Sci (Lond). 2022 05 27; 136(10):715-731. PMID: 35502764; PMCID: PMC9851172.
    Citations: 1     Fields:    Translation:AnimalsCells
  16. Ingelfinger JR. Childhood Risk Factors and Prediction of Adult Cardiovascular End Points. N Engl J Med. 2022 05 19; 386(20):1948-1949. PMID: 35373934.
    Citations:    Fields:    Translation:Humans
  17. Ingelfinger JR. Hematuria in Adults. Reply. N Engl J Med. 2021 10 07; 385(15):e51. PMID: 34614343.
    Citations:    Fields:    Translation:Humans
  18. Williams WW, Hogan JW, Ingelfinger JR. Time to Eliminate Health Care Disparities in the Estimation of Kidney Function. N Engl J Med. 2021 11 04; 385(19):1804-1806. PMID: 34554659.
    Citations: 7     Fields:    Translation:Humans
  19. Ingelfinger JR. Can Salt Substitution Save At-Risk Persons from Stroke? N Engl J Med. 2021 09 16; 385(12):1137-1138. PMID: 34459568.
    Citations: 1     Fields:    Translation:Humans
  20. Williams WW, Ingelfinger JR. Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients. N Engl J Med. 2021 09 23; 385(13):1233-1234. PMID: 34379913; PMCID: PMC8385552.
    Citations: 6     Fields:    Translation:Humans
  21. Miyata KN, Lo CS, Zhao S, Zhao XP, Chenier I, Yamashita M, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD. Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes. Diabetologia. 2021 11; 64(11):2589-2601. PMID: 34370045; PMCID: PMC8992778.